These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1647532)

  • 41. An etorphine-evoked vagal reflex in rats is inhibited by naloxone, N-methylnaloxone, and SMS 201-995.
    Dashwood MR; Kiang JG; Wei ET
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):77-82. PubMed ID: 6198981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
    Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
    Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perfusion of the fourth cerebral ventricle with fentanyl induces naloxone-reversible bradycardia, hypotension, and EEG synchronisation in conscious dogs.
    Freye E; Arndt JO
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jun; 307(2):123-8. PubMed ID: 481612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential affinity labels for the opiate receptor based on fentanyl and related compounds.
    Maryanoff BE; Simon EJ; Gioannini T; Gorissen H
    J Med Chem; 1982 Aug; 25(8):913-9. PubMed ID: 6288945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of morphine, etorphine and enkephalins with dopamine-stimulated adenylate cyclase of monkey amygdala.
    Walczak SA; Wilkening D; Makman MH
    Brain Res; 1979 Jan; 160(1):105-16. PubMed ID: 214205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of etorphine on dopamine and noradrenaline concentrations in different central nervous system structures in the rat.
    Kania BF
    Acta Physiol Pol; 1977; 28(6):529-40. PubMed ID: 612138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat.
    Leighton GE; Rodriguez RE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Mar; 93(3):553-60. PubMed ID: 2836010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible presynaptic inhibitory effect of etorphine on sympathetic nerve terminals of guinea-pig heart.
    Ledda F; Mantelli L
    Eur J Pharmacol; 1982 Nov; 85(2):247-50. PubMed ID: 6295783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of ganglionic transmission by narcotic analgesics; an effect antagonized by naloxone, nalorphine and calcium.
    Minker E; Végh A; Blazsó G
    Acta Physiol Acad Sci Hung; 1981; 58(2):157-62. PubMed ID: 6122334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spinal and supraspinal effects of pertussis toxin on opioid analgesia.
    Shah S; Duttaroy A; Davis T; Yoburn BC
    Pharmacol Biochem Behav; 1994 Nov; 49(3):773-6. PubMed ID: 7862737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats.
    Petrillo P; Gambino MC; Tavani A
    Life Sci; 1984 Aug; 35(9):917-27. PubMed ID: 6381949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Etorphine inhibition of pancreatic exocrine secretion in rats: comparison with methadone.
    Chariot J; Appia F; Vaille C; Rozé C
    Eur J Pharmacol; 1986 Feb; 121(1):73-81. PubMed ID: 3956574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-tolerance between analgesic low doses of morphine and naloxone in arthritic rats.
    Kayser V; Guilbaud G
    Brain Res; 1987 Mar; 405(1):123-9. PubMed ID: 3032345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor.
    Taiwo YO; Basbaum AI; Perry F; Levine JD
    J Pharmacol Exp Ther; 1989 Apr; 249(1):97-100. PubMed ID: 2540325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conformation-activity relationships of opiate analgesics.
    Martin J; Andrews P
    J Comput Aided Mol Des; 1987 Apr; 1(1):53-72. PubMed ID: 2905731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study of gastrointestinal opiate receptors: the role of the Mu receptor on gastric emptying: concise communication.
    Lamki L; Sullivan S
    J Nucl Med; 1983 Aug; 24(8):689-92. PubMed ID: 6308189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.